INTRODUCTION
============

With the advance of genome characterization technology, high-throughput genomic and proteomic data of patients have accumulated rapidly, allowing the systematic identification of biomarkers ([@gks386-B1; @gks386-B2; @gks386-B3; @gks386-B4]). Biomarkers that correlate with patient survival data are of particular interest because they provide a critical foundation for the diagnosis and treatment of disease ([@gks386-B5],[@gks386-B6]). Conventionally, such an analysis is based on individual genes. However, the results thereby obtained are often noisy and difficult to interpret the underlying mechanisms of disease. Biological networks (e.g. gene regulatory networks or protein interaction networks) represent a reasonable way to summarize the functional behaviours of components within a biological system ([@gks386-B7; @gks386-B8; @gks386-B9]). Therefore, using a biological network as the searching platform, network-based biomarkers (i.e. a group of functionally related genes or proteins) are expected to be more robust and provide valuable insights into the molecular mechanisms of disease. Previous studies ([@gks386-B10],[@gks386-B11]) on this topic have focused on other clinical data (such as metastasis status), and the utility of patient survival data has not been explored.

In this study, we introduce SurvNet, a novel bioinformatics web server for identifying network-based biomarkers that most correlate with patient survival data. The web server takes three input files: one biological network file, one molecular profiling file and one patient survival data file. In order to identify network-based biomarkers, SurvNet uses established algorithms ([@gks386-B10; @gks386-B11; @gks386-B12]) for searching and evaluating the biomarkers. As the output, SurvNet generates a user-friendly display of network-based biomarkers. We expect SurvNet to be a valuable bioinformatics tool for the biomedical community.

MATERIALS AND METHODS
=====================

The computational approach used by SurvNet to identify network-based biomarkers consists of three component processes: (i) a scoring function (combining the subnetwork property, molecular profile and patient survival data), (ii) a searching algorithm (for finding the candidate biomarkers) and (iii) an evaluation (validating the statistical significance of the biomarkers).

Scoring function
----------------

SurvNet first evaluates each gene (node) *i* by calculating the *P*-values *p~i~* from a univariable Cox proportional hazards regression model ([@gks386-B13],[@gks386-B14]), which quantifies how significantly the molecular profiling data of the gene correlate with the patient survival data. Then, each gene *i* is assigned a *z*-score *s~i~* transformed from *p~i~*, as the score for each node in the network, where *Φ*^−1^ is the inverse standard normal cumulative distribution function ([@gks386-B12]). For random data, *p~i~* follows a uniform distribution from 0 to 1, and by the transformation, *s~i~* follows a standard normal distribution, with smaller *p~i~* corresponding to larger *z*-scores.

The scoring function *F* of a subnetwork *G* with *n* genes is calculated by an aggregate *z*-score ([@gks386-B12]), where *F~G~* follows a standard normal distribution if the *s~i~* are independently drawn from a standard normal distribution. According to the formula, *F~G~* is independent with a subnetwork of size *n*. Therefore, subnetworks with different sizes are comparable under this score function.

Searching algorithm
-------------------

Because finding the connected subnetworks with the maximal score is *NP*-hard ([@gks386-B12]), SurvNet uses a greedy searching algorithm, as previously described ([@gks386-B10; @gks386-B11; @gks386-B12]). The searching starts from a seeded gene *i* and expands iteratively. The algorithm will terminate and output the candidate subnetworks if no candidate gene *j* around the current subnetwork *G* satisfies the following two conditions: (i) the number of edges in the shortest path between *j* and seeded gene *i* is smaller than or equal to *δ* and (ii) the score of subnetwork *G* with gene *j* is higher than (1 + *ρ*) \* *F~G~*, where *δ* and *ρ* are two pre-determined parameters. Specifically, *δ* is used to reduce the searching space and *ρ* is a fixed increasing rate, ensuring that a new gene added to the subnetwork must increase the network score *F~G~* by a rate larger than or equal to *ρ*.

Evaluation
----------

SurvNet evaluates the statistical significance of the subnetworks identified in the searching step, as previously described ([@gks386-B12]). It first uses random sampling to see if the score of a subnetwork is significantly higher than that of a random gene set in the network. To do so, SurvNet randomly samples gene sets with *n* genes 10 000 times. Then, the same scoring function is used to calculate the scores for the random gene sets. The population mean *μ~n~* and standard deviation *σ~n~* are estimated from the sampled gene sets. Finally, *F~G~* is calibrated against this background distribution as follows:

This calibrated score is the final network score for a subnetwork in the output. Moreover, since the multivariable Cox proportional hazards regression model is widely used to quantify the correlation between a group of genes and patient survival data, SurvNet also calculates the mutivariable Cox *P*-values for each subnetwork to validate their clinical utility. One potential advantage of SurvNet is to identify key disease genes that could have been missed through single-gene based analyses. For example, TP53 is a master cancer gene in ovarian carcinoma. Based on the protein expression and patient survival data from a recent study ([@gks386-B1]), TP53 protein, as a single node, shows no significant correlation with the patient survival, but a TP53-centered network is among the top biomarkers SurvNet identifies.

WEB SERVER
==========

Input
-----

The web server accepts three input files. The first one is a biological network file, representing a gene regulatory or protein interaction network \[a human protein--protein interaction network ([@gks386-B15]) is provided as the default\]. This file contains all the edges of a biological network, in which each line represents an edge. The second file is one molecular profiling file, containing any type of gene- or protein-centred high-throughput biological data (e.g. microarray-based gene expression data, reverse-phase protein array ([@gks386-B16]) protein expression data, DNA methylation data or gene mutation data). This file is a tab-separated numeric matrix, where the column names are the sample IDs and row names are gene IDs. The third file is one patient survival data file (e.g. patients' overall survival time or progression-free survival time). This file has three columns, named 'id', 'censor' and 'time', respectively.

After uploading the required input files, users can set the search distance ([Figure 1](#gks386-F1){ref-type="fig"}A). This parameter defines the searching area in the network: start with each valid gene (or protein) node as the seed, SurvNet will automatically search for the optimal subnetwork(s) within this defined distance. SurvNet uses the same network searching algorithm that was previously described ([@gks386-B10],[@gks386-B11]). A larger parameter will require a longer computation time. The default search distance is 2. Figure 1.Snapshots of the SurvNet web server. (**A**) Input page, through which input files and a search parameter can be specified. (**B**) Output page, on which the top subnetwork biomarkers identified are displayed. (**C**) Visualization page, on which subnetworks can be visualized in a user-friendly way.

Output
------

In the final output, the subnetworks that SurvNet identifies will first be displayed in a table format ([Figure 1](#gks386-F1){ref-type="fig"}B). These results can be directly downloaded. The network files are in a '.dot' format that can be visualized by GraphViz (<http://www.graphviz.org>). As shown in [Figure 1](#gks386-F1){ref-type="fig"}C, the identified subnetworks are ranked within the table according to the network score, from high to low score. Each score is associated with the output items that follow. The network score, which quantifies how significantly the nodes in a subnetwork correlate with the observed patient survival data, is calculated based on the univariable Cox proportional hazards model and the network properties. A higher network score indicates a more significant correlation between the network and the patient survival time. The 'Cox *P*-value' is the *P*-value derived from the multivariable Cox proportional hazards regression model. The 'gene_ID' indicates the seeded node for each subnetwork; the number of nodes indicates how many genes (or proteins) are in the subnetwork; and the number of edges indicates how many interactions are in the subnetwork. Users can further narrow down the results by two output parameters: network *P*-value cut-off and minimal number nodes. The network *P*-value cut-off determines how significant the returned subnetworks are compared to the random background; and the default significance level is 0.05. Minimal number nodes determine the minimal number of nodes in a subnetwork; the default value is 2.

After clicking the 'Graph' button in the final output page, users can visualize an identified subnetwork in a user-friendly Java applet that allows them to pan/zoom, search and retrieve useful information (from GeneCard) for a node of interest. A detailed description about the Java applet is available under the visualization page.

CONCLUSION
==========

We have developed SurvNet, a web server that can efficiently identify network-based biomarkers that most correlate with patient survival data. To the best of our knowledge, SurvNet is the only available bioinformatics tool for this function. SurvNet uses the network-based biomarker searching algorithms that were established in previous studies, and provides a user-friendly interface for exploring the identified biomarkers. We expect SurvNet to be a valuable resource for generating meaningful hypotheses for disease diagnosis and treatment.
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